More patients treated with ZTlido® saw either a decrease or discontinuation of opioid use compared with those treated with the 5% patch (51.9% ...

In the study, 51.9% of ZTlido® patients experienced decreased or discontinued opioid use, compared to 45.5% with the 5% patch, with more ZTlido® patients reporting at least a 20% reduction in ...

A key finding indicated that 51.9% of patients treated with ZTlido® experienced either a decrease or a halt in opioid use, compared to 45.5% of those using the 5% lidocaine patch. Furthermore ...

AVERSA™ Fentanyl Advances Toward Commercialization Our lead product, AVERSA™ Fentanyl, is poised to become the world’s first abuse-deterrent opioid transdermal patch. We made significant ...

When Indiana was hit hard by the opioid epidemic, so was Decatur County. Since then, Indiana, including Decatur County, has been doing its best to push back against the opioid epidemic. The Indiana ...

ORLANDO, Fla., Dec. 31, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders highlighting the ...

A key finding indicated that 51.9% of patients treated with ZTlido® experienced either a decrease or a halt in opioid use, compared to 45.5% of those using the 5% lidocaine patch. Furthermore, a ...